Inflammatory Bowel Disease (IBD) centers dealing with patients having chronic conditions had to quickly adapt to use home monitoring tools during the COVID-19 pandemic, including IBDoc®, as a mean to safely test fecal calprotectin.
South Korea’s biotechnology firm Seegene (KQ096530) said Monday it developed the world’s first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.
This website uses cookies to give you the best, most relevant experience. By continuing to browse the site you are agreeing to our use of cookies defined in our Privacy Policy.OkRead more
Social Links